Introduction: A Turning Point for Indonesia’s Food Industry Indonesia just made a major move. As of April 2026, BPOM Nutri-Level Indonesia has officially entered the regulatory scene, reshaping how food and beverage products must communicate nutritional information to consumers. For every business operating in Indonesia’s food and beverage sector, whether
Indonesia is no longer just a transit point for ASEAN trade. With a population of over 270 million people and a rapidly expanding middle class, it has become one of the most attractive food and beverage markets in the region. Yet many foreign brands hit an unexpected wall before their
Supplement registration in Indonesia is one of the most important steps any foreign brand or exporter must complete before a single product can legally reach an Indonesian consumer. With over 277 million people, a rapidly growing health-conscious middle class, and an economy on a steady upward trajectory, Indonesia represents one
Indonesia’s supplement market is booming. For foreign brands, probiotics represent one of the most promising entry points. But before a single capsule reaches an Indonesian shelf, it must navigate one of Southeast Asia’s most rigorous regulatory frameworks. BPOM probiotic regulation in Indonesia has undergone a major overhaul in 2025. The
Entering the Indonesian health and wellness market offers a massive opportunity for international brands. However, the gatekeeper to this market is the Indonesian Food and Drug Authority, known as BPOM (Badan Pengawas Obat dan Makanan). Achieving a successful BPOM registration is the most critical milestone for any manufacturer or distributor.
The landscape of food safety in Southeast Asia is shifting toward higher accountability and more rigorous oversight. On January 6, 2025, the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan) officially enacted a pivotal BPOM regulation regarding the Recall and Destruction of Processed Food. This update is not
As Indonesia’s market for Natural Medicines (OBA) and Health Supplements (SK) continues to surge, the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has intensified its focus on a “silent” danger: Heavy Metal Contamination. Unlike bacteria, heavy metals cannot be killed with heat; they are invisible, tasteless, and
For manufacturers and consumers of Natural Medicines (OBA) and Health Supplements (SK) in Indonesia, understanding the risks of microbial contamination is vital. The BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has highlighted the dangers of Enterobacteriaceae, a family of Gram-negative bacteria that includes notorious pathogens like E.
The recent collaboration between Indonesia’s National Agency of Drug and Food Control (BPOM) and the Guangxi Drug Administration marks a significant milestone in BPOM registration for Chinese pharmaceutical companies seeking structured and compliant entry into the Indonesian market. This partnership signals a deeper level of regulatory engagement between the two
For manufacturers of Traditional Medicine (OBA), Quasi-Drugs (OK), and Health Supplements (SK) in Indonesia, the term “human error” is often used as a convenient conclusion for production deviations. However, according to the latest guidance from the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements, treating human error as
Introduction: A Turning Point for Indonesia’s Food Industry Indonesia just made a major move. As of April 2026, BPOM Nutri-Level Indonesia has officially entered the regulatory scene, reshaping how food and beverage products must communicate nutritional information to consumers. For every business operating in Indonesia’s food and beverage sector, whether
Indonesia is no longer just a transit point for ASEAN trade. With a population of over 270 million people and a rapidly expanding middle class, it has become one of the most attractive food and beverage markets in the region. Yet many foreign brands hit an unexpected wall before their
Supplement registration in Indonesia is one of the most important steps any foreign brand or exporter must complete before a single product can legally reach an Indonesian consumer. With over 277 million people, a rapidly growing health-conscious middle class, and an economy on a steady upward trajectory, Indonesia represents one
Indonesia’s supplement market is booming. For foreign brands, probiotics represent one of the most promising entry points. But before a single capsule reaches an Indonesian shelf, it must navigate one of Southeast Asia’s most rigorous regulatory frameworks. BPOM probiotic regulation in Indonesia has undergone a major overhaul in 2025. The
Entering the Indonesian health and wellness market offers a massive opportunity for international brands. However, the gatekeeper to this market is the Indonesian Food and Drug Authority, known as BPOM (Badan Pengawas Obat dan Makanan). Achieving a successful BPOM registration is the most critical milestone for any manufacturer or distributor.
The landscape of food safety in Southeast Asia is shifting toward higher accountability and more rigorous oversight. On January 6, 2025, the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan) officially enacted a pivotal BPOM regulation regarding the Recall and Destruction of Processed Food. This update is not
As Indonesia’s market for Natural Medicines (OBA) and Health Supplements (SK) continues to surge, the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has intensified its focus on a “silent” danger: Heavy Metal Contamination. Unlike bacteria, heavy metals cannot be killed with heat; they are invisible, tasteless, and
For manufacturers and consumers of Natural Medicines (OBA) and Health Supplements (SK) in Indonesia, understanding the risks of microbial contamination is vital. The BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has highlighted the dangers of Enterobacteriaceae, a family of Gram-negative bacteria that includes notorious pathogens like E.
The recent collaboration between Indonesia’s National Agency of Drug and Food Control (BPOM) and the Guangxi Drug Administration marks a significant milestone in BPOM registration for Chinese pharmaceutical companies seeking structured and compliant entry into the Indonesian market. This partnership signals a deeper level of regulatory engagement between the two
For manufacturers of Traditional Medicine (OBA), Quasi-Drugs (OK), and Health Supplements (SK) in Indonesia, the term “human error” is often used as a convenient conclusion for production deviations. However, according to the latest guidance from the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements, treating human error as
Enter your email to get the document delivered to your inbox.
